CC

Crt Cencelj

Active Director Director DIN 07525441
DIN 07525441 First appointment May 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2016
Shareholding value •••• Premium profile

About Crt Cencelj

Data last updated:

Crt Cencelj is a Director at Inel Pharmaceutical Systems Private Limited (since 2016). The company operates in Pharma. Inel Pharmaceutical Systems Private Limited reported revenue of ₹5.8 Lakh (FY 2018).

DIN 07525441
Primary Designation Director
Industry Pharma
First Appointment 24 May 2016
Oldest Company Age 11 yrs
Largest company Inel Pharmaceutical Systems Private Limited · ₹5.8 Lakh (FY 2018)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 May 20162015₹5.8 Lakh (FY 2018)Active

Board colleagues of Crt Cencelj

NameDINCompanyDesignation
Ivan Cencelj07525456Inel Pharmaceutical Systems Private LimitedDirector

Directorship timeline

Open interactive timeline →
Inel Pharmaceutical Systems Private Limited
Premium access

Shareholding and investment profile for Crt Cencelj

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Crt Cencelj

Crt Cencelj currently holds 1 directorship: Inel Pharmaceutical Systems Private Limited (Director, since 24 May 2016, revenue ₹5.8 Lakh (FY 2018)).

Crt Cencelj was first appointed on 24 May 2016 as Director at Inel Pharmaceutical Systems Private Limited.

The current boards of Crt Cencelj's companies include Ivan Cencelj (Inel Pharmaceutical Systems Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available